Israel Englander Kiniksa Pharmaceuticals, Ltd. Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$17.63 - $21.74 $3.33 Million - $4.11 Million	-188,926 Reduced 44.11%	239,409 $4.72 Million
Q4 2023 Feb 14, 2024	BUY	$14.37 - $19.07 $1.37 Million - $1.82 Million	95,589 Added 28.73%	428,335 $7.51 Million
Q2 2023 Aug 14, 2023	SELL	$10.44 - $16.48 $3.06 Million - $4.84 Million	-293,452 Reduced 46.86%	332,746 $4.69 Million
Q1 2023 May 15, 2023	SELL	$10.7 - $15.79 $1.55 Million - $2.28 Million	-144,452 Reduced 18.74%	626,198 $6.74 Million
Q4 2022 Feb 14, 2023	SELL	$11.42 - $17.05 $1.97 Million - $2.94 Million	-172,549 Reduced 18.29%	770,650 $11.5 Million
Q3 2022 Nov 14, 2022	BUY	$9.76 - $13.41 $6.65 Million - $9.14 Million	681,827 Added 260.86%	943,199 $12.1 Million
Q2 2022 Aug 15, 2022	SELL	$7.6 - $11.41 $5.52 Million - $8.29 Million	-726,906 Reduced 73.55%	261,372 $2.53 Million
Q1 2022 May 16, 2022	BUY	$9.3 - $12.37 $4.28 Million - $5.7 Million	460,475 Added 87.24%	988,278 $9.82 Million
Q4 2021 Feb 14, 2022	BUY	$10.39 - $15.15 $3.12 Million - $4.55 Million	300,288 Added 131.99%	527,803 $6.21 Million
Q3 2021 Nov 15, 2021	SELL	$11.39 - $16.23 $2.51 Million - $3.58 Million	-220,695 Reduced 49.24%	227,515 $2.59 Million
Q2 2021 Aug 16, 2021	SELL	$13.22 - $19.09 $322,911 - $466,292	-24,426 Reduced 5.17%	448,210 $6.24 Million
Q1 2021 May 17, 2021	BUY	$16.68 - $23.97 $3.71 Million - $5.33 Million	222,242 Added 88.76%	472,636 $8.75 Million
Q4 2020 Feb 16, 2021	SELL	$14.8 - $21.15 $1.52 Million - $2.17 Million	-102,635 Reduced 29.07%	250,394 $4.42 Million
Q3 2020 Nov 16, 2020	BUY	$15.21 - $25.53 $1.99 Million - $3.34 Million	130,783 Added 58.85%	353,029 $5.41 Million
Q2 2020 Aug 14, 2020	BUY	$15.08 - $26.0 $642,664 - $1.11 Million	42,617 Added 23.73%	222,246 $5.66 Million
Q1 2020 May 14, 2020	SELL	$11.0 - $19.76 $327,712 - $588,689	-29,792 Reduced 14.23%	179,629 $2.78 Million
Q4 2019 Feb 14, 2020	BUY	$5.24 - $12.96 $1.1 Million - $2.71 Million	209,421 New	209,421 $2.32 Million
Q2 2019 Aug 14, 2019	SELL	$13.2 - $20.39 $410,124 - $633,517	-31,070 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$15.93 - $26.59 $1.2 Million - $2 Million	-75,336 Reduced 70.8%	31,070 $561,000
Q4 2018 Feb 14, 2019	SELL	$16.25 - $28.09 $1.88 Million - $3.25 Million	-115,644 Reduced 52.08%	106,406 $2.99 Million
Q3 2018 Nov 14, 2018	BUY	$13.23 - $30.93 $2.64 Million - $6.17 Million	199,631 Added 890.45%	222,050 $5.66 Million
Q2 2018 Aug 14, 2018	BUY	$16.73 - $20.35 $375,069 - $456,226	22,419 New	22,419 $389,000

Others Institutions Holding KNSA

# of Institutions

Shares Held

1.95M

Call Options Held

Put Options Held

Pictet Asset Management Sa Geneva 73, V8

1.52M
Shares

$32.3 Million
0.03% of portfolio
Spearhead Capital Advisors, LLC Wellington, FL

203K
Shares

$4.31 Million
2.82% of portfolio
Harbor Capital Advisors, Inc.

97.5K
Shares

$2.08 Million
0.11% of portfolio
Putnam Investments LLC Boston, MA

39.5K
Shares

$840,262
0.0% of portfolio
Birchview Capital, LP Burlington, VT

30K
Shares

$638,400
0.69% of portfolio

View Full List

About Kiniksa Pharmaceuticals, Ltd.

Ticker KNSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,470,400
Market Cap $734M
Description
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...

More about KNSA

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account